Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Yea currently holds 226,701 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Yea has been a net seller of KALV stock. They have purchased $0 and sold $3.7M worth of shares.
Christopher Yea's most recent insider trade was on Feb 23, 2026, when they sold 4,347 shares at $15.57 per share.
Christopher Yea serves as Executive at KalVista Pharmaceuticals, Inc. (KALV). They have executed 96 insider transactions totaling $3.7M over their tenure at the company.
Christopher Yea holds the position of Executive at KalVista Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Christopher Yea has shown a selling trading pattern, with $0 in total purchases and $3.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Yea was on Feb 14, 2024, when they sold $598.7K worth of KALV shares. This transaction involved 39,886 shares at $15.01 per share.
Christopher Yea currently owns 226,701 shares of KalVista Pharmaceuticals, Inc. (KALV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Yea's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Yea has 96 Form 4 filings on record as an insider at KalVista Pharmaceuticals, Inc..
Set alerts for Christopher Yea and 40,000+ other insiders.